TARTIS, INC.

Basic Information

384 SUMMER STREET
BUFFALO, NY, 14213

Company Profile

n/a

Additional Details

Field Value
DUNS: 830048422
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel Hematopoietic Conditioning Agents for Treatment of Hematological Diseases

    Amount: $112,885.00

    DESCRIPTION (provided by applicant): Hematopoietic stem cell transplantation (HSCT) has increased the survival of children and adults afflicted with malignant and non-malignant hematological diseases. ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. New type of androgen receptor inhibitors for prostate cancer treatment

    Amount: $107,428.00

    DESCRIPTION (provided by applicant): Hormone refractory prostate cancer (HRPC) is a life threatening disease that cannot be treated with currently available drugs, most of which target interaction of ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government